Gold Coast Health & Knowledge Precinct
Transform with us
The Precinct is home to a number of leading research institutes, spanning Life Sciences, health, environmental research and urban planning, ICT, advanced manufacturing, engineering and micro and nano-technology.
Many leading researchers are focused on translation and commercialisation of their research outcomes and welcome industry partnerships.
From malaria to the deadly Strep A bacteria and the world’s largest critical mass in cancer glycomics, the Institute for Biomedicine and Glycomics is the only facility of its kind in Australia and one of only a handful in the world tackling diseases of global impact at the new frontier of biomedical research – glycomics – cracking the ‘carbohydrate code’ and the crucial role carbohydrates play in diseases.
Founded in 2000, the Institute boasts more than 200 research and support staff, including Professor Michael Good AO, who has vaccines for both Malaria and Strep A bacteria in human clinical trials.
The Institute provides a multidisciplinary approach to research and education, spanning medicinal and computational chemistry and various biological and physical sciences. A comprehensive portfolio of research programs focuses on some of the most significant viral pathogens (influenza, parainfluenza, dengue virus, HIV and emerging alphaviruses); bacterial infections (N. meningitidis, N. gonorrhoeae and Group A Streptococcus); parasitic diseases (including the malaria vaccine, PlasProtecT® currently in human clinical trials); and cancers. It also hosts the Australian Centre for Cancer Glycomics, a world-leading cluster of researchers.
The Institute boasts a range of cutting-edge research facilities and equipment – a Glycobioanalytical facility (including glycan array and bioanalytical suite), a Flow Cytometry facility offering high-end instrumentation and expertise for cell/particle analysis and sorting; and specialised nuclear magnetic resonance and spectroscopy and protein x-ray crystallography equipment.
Part of Griffith’s Environmental Futures Institute, the Centre for Catalysis and Clean Energy is a leading multi-disciplinary centre focused on developing environmental and clean energy solutions, including using innovative nanotechnologies to develop new materials. The CCEE boasts broad expertise across environment and pollution chemistry, environmental microbiology, geochemistry, sensing technology, electrochemistry, biochemistry and biotechnology, photochemistry and photocatalysis, membrane science and nanotechnology.
The Cities Research Institute brings together expertise across a range of academic disciplines, with strong multidisciplinary research to understand and meet urban challenges.
Incorporating the Griffith Centre for Coastal Management the Institute has particular expertise in coastal resilience and urban water, with other focus areas including smart cities, intelligent infrastructure and digital technologies for energy and water utilities and building science and construction innovation. The institute collaborates with governments, industry and community across Australasia and the Asia Pacific.
Opened in March 2018, the state-of-the-art showcase laboratory includes a new $1.2 million medical-grade 3D printer. Also boasting a range of other high-tech equipment and advanced digital design capabilities, it's a test platform for working with a range of industries on rapid prototyping projects.
The GCHKP is rapidly developing a strong clinical trial capacity, leveraging Australia’s reputation for excellence and innovation in clinical trials.
From Phase I-IV, clinical trials are catered for in both hospital and university facilities for a range of drugs, vaccines and therapeutic treatments.